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Summary  
Compared to controls, the lateral and medial tibial articular cartilage chondroitin sulfate (CS) content in male STR/Ort 
mice was elevated between 8 and 19 weeks of age, fell at 24-26 weeks and increased again thereafter. The CS cartilage 
content of CBA mice remained relatively unchanged. 
Cartilage CS content was measured in female CBA and STR/Ort mice and in male and female Balb C mice, all at 
18 weeks of age. In every case the content was much lower than that found in male STR/Ort mice. 
CS unsaturated disaccharides were analysed by capillary electrophoresis after digestion of the glycosaminoglycans 
with chondroitinase ABC. Chondroitin-4-sulfate (C4S) was the predominant isomer at all ages in both strains. The 
C4S: C6S isomer atio in CBA mice was much higher in the lateral than the medial cartilage. This difference was much 
less marked in STR/Ort knee joints: these mice have relatively more C6S than CBA mice. 
Proteoglycans, extracted from STR/Ort and CBA male mouse cartilage, were characterized by large pore gel 
electrophoresis and Western blotting. All cartilages contained two slow mobility bands identified as aggrecan by the 
reactivity with the mab 1C6. Both bands contained C4S and C6S chains. A third band of faster mobility contained only 
C4S and was 1C6 negative~ It was present in both strains. Thus the STR/Ort cartilage contained a normal spectrum 
of murine articular cartilage proteoglycans. 
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I n t roduct ion  
ANIMAL MODELS of human disorders provide infor- 
mat ion about  biochemical  changes in tissues pre- 
ceding overt  expression of disease. The Pond-Nuki  
model has been invest igated extensively in osteo- 
arthr i t is  (OA). The model is acutely induced by 
sect ioning the canine anter ior  cruciate l igament 
[1] and produces a rapid deter iorat ion of the artic- 
u lar  cart i lage [2]. Ear ly  changes occur  in the 
b iochemistry of the art icu lar  cart i lage proteogly- 
cans [3, 4]. In contrast  to induced disease, early 
biochemical  changes in natura l ly -occurr ing ani- 
mal osteoarthroses have been less well studied. 
STR/Ort  mice provide a wel l -character ized 
model of id iopathic OA [5]. About 85% of male 
STR/Ort  mice develop histological  esions in the 
medial t ibial p lateau which closely resemble those 
of human OA. Lesions develop from about  20 weeks 
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of age, usual ly in the cart i lage adjacent to the 
insert ion of the anter ior  cruc iate  l igament, and 
may progress to involve all areas of the medial  
plateau. The lateral  condyle is almost a lways 
spared. 
The STR/Ort  l ine was developed from the 
STR/1N line [6]. Proteoglycans  extracted from 
STR/1N mouse art icu lar  cart i lage showed no 
differences in their  abi l i ty to aggregate, nor  in the 
sulfat ion of their  g lycosaminoglycans,  rat io  of 
chondroit in-4-sulfate (C4S) to chondroit in-6-sulfate 
(C6S), b~ l ink proteins, when compared to STR 
control  mice, which have a much lower inc idence 
of OA [7]. However,  4 M guanidine hydrochlor ide 
extracted a greater  proport ion of 85S-labelled pro- 
teoglycan from the art icu lar  cart i lage of STR/1N 
mice compared to controls.  No quant i tat ive  
biochemical  measurements  of the proteoglycan 
content  of e i ther  STR/1N or STR/Ort  cart i lage 
have been reported. However,  several  ear ly meta- 
bolic d isturbances have been found in the latter.  
Histochemical  studies by Al tman [8] indicated that  
lactate dehydrogenase and succinate dehydrogen- 
ase deficiency is present in chondrocytes pr ior  to 
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major histological evidence of degeneration. Also, 
there are changes in the orientation of the articu- 
lar cartilage proteoglycans and a disturbance in 
the activity of chondrocyte glucose-6-phosphate 
dehydrogenase [9, 10]. Recently, Chambers et al. 
[11] reported abnormal activity and distribution of 
monoamine oxidase in male STR/Ort mice. 
We have taken advar_tage of recent technical 
developments to investigate the structure of 
articular cartilage proteoglycans during the 
development of idiopathic OA in male STR/Ort 
mice and to compare this with age-matched control 
CBA mice. The aim was to investigate whether 
changes in proteoglycan structure and content 
precede overt expression of disease. 
Mater ia l s  and  Methods  
MAINTENANCE OF THE STR/ORT COLONY 
A colony was established from breeding pairs of 
STR/Ort mice obtained from Harlan Olac Ltd 
(Shaw's Farm, Blackthorn, Bicester, Oxon., 
OX6 OTP, U.K.). The animals were inbred by strict 
sister-brother mating. Mice were maintained on a 
diurnal rhythm of 12 h light, 12 h dark (tempera- 
ture, 20-21°C; humidity, 40-50~/o) and all the 
animals were fed with irradiated CRM nuts 
(Special Diet Services, Witham, Essex, U.K.). Mice 
were caged in groups of up to 4-5 animals, since 
their behaviour was docile. 
EXTRACTION OF MOUSE TIBIAL PLATEAU CARTILAGE 
Full thickness medial and lateral tibial plateau 
articular cartilage was dissected from STR/Ort 
mice of about 9, 17, 25, 32 and 45 weeks and from 
age-matched CBA control mice. The cartilage was 
transferred to pre-weighed and pre-cooled Eppen- 
dorf tubes which were sealed rapidly to prevent 
water loss, and re-weighed to obtain the cartilage 
wet weight. Proteoglycans were extracted with a 
sequential procedure (4 M guanidine HC1 
(GuHC1); ultrapure collagenase, 4M guanidine 
HC1; NaOH) [12] or with 0.5 m NaOH alone. Car- 
tilage was extracted on a rotary shaker at 4°C for 
48h with 100/~1 of 4M GuHC1 (El) containing 
protease inhibitors (100mM aminohexanoic acid, 
10 mM Na2 EDTA, 5 mM benzamide HC1, 1 mM N- 
ethylmaleimide, 1 mM phenyl methyl sulfonylfluo- 
ride; Sigma Chemical Co.). After centrifugation, 
the tubes were placed on ice and the supernatant 
removed using duck-billed pipette tips (Bioquote 
Ltd, The Raylor Centre, James  Street, York, 
North Yorkshire, YO1 3DW, U.K.). The cartilage 
residues were washed twice with 100pl Tris 
washing buffer (1 mM Tris-HC1, 2 mM CaC12, pH 
7.2) to remove the GuHC1 and then incubated 
with 100#l buffer (25mM Tris-HC1, 10mM CaC1, 
150mM NaC1) containing 132 units of type IH 
collagenase (Advanced Biofactures, New York) 
and protease inhibitors (0.1 mM pepstatin, 0.1 mM 
leupeptin, 5 mM N-ethylmaleimide and 1 mM 
phenyl methyl sulfonylfluoride; Sigma Chemical 
Co.) at 37°C for 48h. After centrifugation, the 
supernatant was removed and the residue ex- 
tracted again with 4 mM GuHC1. The supernatant 
was combined with that from the collagenase di- 
gest (E2). Finally 100t£1 of 0.5M NaOH were 
added to the tissue residuel and the tubes incu- 
bated at 4°C for 24h on a rotary shaker (E3). 
Some samples were extracted with alkali alone, 
using the same protocol as described for E3. All 
the extract supernatants were stored at -20°C 
before drop dialysis and freeze drying. 
DROP DIALYSIS AND FREEZE DRYING 
To remove buffer salts, GuHC1, or NaOH, the 
supernatants were diluted twice with distilled 
water and subjected to 24 h drop-dialysis at 4°C. 
Due to the small sample volume, dialysis was 
performed in inverted Eppendorf tubes with the 
centre of their lids cut out. The dialysis mem- 
brane was stretched across the lid and held be- 
tween the lid and the body of the Eppendorf. 
After dialysis, the samples were snap frozen and 
freeze dried using an Edwards Super Modulyo 
freezer dryer. 
CHONDROITINASE ABC DIGESTIONS 
After drop dialysis and freeze drying, one-sixth 
of the total alkali extracts were saved for 
1°3ruthenium red dot blot analysis to quantitate 
glycosaminoglycans. This assays low nanogram 
amounts of glycosaminoglycan, and its use to 
measure murine articular cartilage glycosamino- 
glycans has been fully described elsewhere [13]. 
The remainder was digested with chondroitin ABC 
lyase (0.03 units/incubation, ICN Biomedicals Ltd, 
High Wycombe, U.K.) in a buffer containing 50 mM 
Tris base, 60 mM sodium acetate, pH 8.0, at 37°C, 
for 3 h. This generated unsaturated chondroitin 
sulfate (CS) disaccharides for subsequent analysis 
by capillary zone electrophoresis (CZE). Samples 
were reduced to dryness by centrifugal evapor- 
ation (30 min, 40°C, Savant Speed Vac SC100) and 
reconstituted in 20 ~1 ultra-pure H20 immediately 
before loading onto the CZE. 
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CAPILLARY ZONE ELECTROPHORESIS 
Unsaturated CS disaccharide isomers were sep- 
arated by the method of Carney and Osborne 
[14] using a CZE apparatus (Model 270 A, Ap- 
plied Biosystems, Warrington, Cheshire, U.K.). 
Standard unsaturated C4S and C6S disaccharides 
(ADi-4S, ADi-6S, ICN Biomedical) were used to 
construct calibration curves against which the 
unknown samples were assayed. Samples and 
standards were loaded by negative pressure (2 s 
load) in a 200mM orthophosphoric acid buffer 
(pH3). Electrophoresis was performed using 
reverse polarity in the same buffer at 15kV, 
40°C on a 72 cm column (50 #m i.d.). The column 
was monitored at 232nm. Before loading, the 
column was pre-washed with 0.1M NaOH for 
2rain followed by a 5min rinse with running 
buffer. 
LARGE PORE GEL ELECTROPHORESIS AND 
WESTERN BLOTTING 
Whole proteoglycans extracted from mouse ar- 
t icular cartilage by 4 M GuHCI(E1) and quantified 
using the l°~ruthenium dot blot assay, were 
separated issociatively on large pore agarose- 
acrylamide slab gels [15]. Samples were dissociated 
overnight in 8 M urea, and 10-15 ng loaded per 
lane. The running buffer was 10 m~ Tris/acetate 
(pH6.8), 0.25mM Na2SO4 and 4M urea. Samples 
were run into the gel at 60 V and then separated at 
160-180 V until the bromophenol blue marker had 
migrated 3cm. Separated proteoglycans were 
transferred on to nylon membranes using a Hoeffer 
semi:dry b lo t te r  apparatus (1 h, 80 mA). The 
blotting buffer was the same as the running buffer 
but without urea. After blocking and chondroiti- 
nase digestion, the membranes were probed with 
monoclonal antibodies (mabs) 3B3 and 2B6 to de- 
tect C6S and C4S linkage region stubs, respectively 
[16]. The membranes were reprobed with mab 
1C6 after reduction and alkylation [17]. This anti- 
body recognizes epitopes in the G1 and G2 
domains of aggrecan and requires prior reduction 
and alkylation for optimum exposure of the 
amino acid sequence-QAAY [18]. Antibody 
binding was detected with an anti-mouse poly- 
valent immunoglobulin linked to horseradish 
peroxidase and visualized by enhanced chemi- 
luminescence using Hyperfilm-MP (Amersham 
International). 
STATISTICAL ANALYSIS 
Statistical analysis was performed using the 
Student's t-test for unpaired data. Data is 
presented in all figures as the mean + S.E.M. 
Resu l ts  
CARTILAGE CS CONTENT 
The total sulfated glycosaminoglycan content of 
murine art icular carti lage was measured using the 
l°aruthenium red assay and expressed as # g/mg wet 
weight of carti lage (Fig. 1). The amount of gly- 
cosaminoglycan in the STR/Ort carti lage was 
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FIG. 1. Quantitation of mouse cartilage glycosaminogly- 
cans~'with the l°%uthenium red assay. Proteoglycans 
were extracted from the lateral (a) and medial (b) tibial 
articular cartilage of STR/Ort ( . )  and CBA mice (f~) 
with either a sequential procedure (4M GuHC1, collagen- 
ase, 4 M GuHC1, NaOH) or with 0.5 M NaOH alone and 
assayed for glycosaminoglycan content using the 
1°3ruthenium red dot blot assay. Results are expressed as 
the mean + S.E.M. from 3-5 animals in each group. In this 
experiment and subsequently, cartilage extracts from 
the left and right legs were analysed separately and the 
data combined. Asterisks denote statistically significant 
differences between CBA and STR/Ort mice: *P < 0.05; 
**P ~< 0.01; ***P ~< 0.002. For the overall mean difference 
between the two strains P ~< 0.002 and <0.001 for lateral 
and medial tibial cartilage respectively. 
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consistent ly h igher  in all age groups than in CBA 
carti lage, by a factor  of between 1.35-3.8 t imes 
(overall  mean difference, P < 0.001 for both medial  
and lateral  t ibial cart i lage; Fig. 1). Pr ior  digest ion 
with chondro i t in  lyase ABC el iminated all 
interact ion with dye, indicat ing that  the 
g lycosaminoglycan is at t r ibutable  solely to 
chondro i t in /dermatan sulfate. 
The mean CS content  of CBA cart i lage in young 
animals (8-9 weeks) was about  5#g/mg.  Simi lar 
values were seen in old animals (41-48 weeks) with 
an apparent  decrease in between these ages (24-26 
weeks). In contrast ,  the CS content  of both the 
medial and lateral  t ibial cart i lage of STR/Ort  mice 
was higher in 8-9-week-old animals (~7.5 pg/mg), 
increased great ly  by 16-19 weeks (~ 16/~g/mg) and 
then decreased great ly  by 24-26 weeks (~ 3 #g/mg). 
Thereaf ter  it increased again as age progressed, 
reaching a level of about  8 #g/mg by 41-48 weeks 
(Fig. 1). 
The CS content  of mur ine art icu lar  cart i lage was 
also measured by assaying C4S and C6S unsatu- 
rated disaccharides by CZE, fol lowing digestion 
with chondroi t inase ABC (Fig. 2). Of the 24 mice 
used for these measurements,  13 were from the 
series used for the dot blot assays above, whilst 11 
were from a new series. The total  d isacchar ide 
content  (ADi - 4S + ADi - 6S) was again much 
greater  in STR/Ort  cart i lage than  in the age- 
matched contro l  CBA cart i lage (P  < 0.001 for the 
overal l  mean dif ference for both lateral  and medial 
plateaux; Fig. 2). The two methods of measurement  
gave results for each age group and strain which 
were general ly  in close agreement  with one 
another  (Figs 1 & 2). However,  the level of proteo- 
glycan in the 17-19 week STR/Ort  mice was not so 
high in the e lectrophoret ic  analysis (Fig. 2) as in 
the dot blot analysis (Fig. 1). Nevertheless,  there 
was a marked fall in the medial cart i lage CS 
content  at 25-26 weeks fol lowed by an increase at 
later ages [Fig. 2(b)]. The fall occurred later  in the 
lateral  cart i lage, but again there was an increase 
in CS levels in older mice [Fig. 2(a)]. In contrast,  
the CS content  in CBA mouse art icu lar  cart i lage 
remained almost constant  across the age range 
studied. No di- or tr isul fated disaccharides were 
found in CS from either  strain. 
The C4S isomer is predominant  at all ages in 
both strains (Fig. 2). In the CBA mice the chon- 
droit in 4:6 sulfate isomer rat io was greater  in the 
lateral  than the medial  tibial p lateau [Fig. 3(a), 
P <0.001 for the overal l  mean difference]. 
However,  this dif ference was far less pronounced 
in the STR/Ort  mice [Fig. 3(b)]. In addition, the 
STR/Ort mice have relat ively more C6S than the 
CBA mice since their  4:6 rat ios  were general ly  
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FIG. 2. Analysis of mouse cartilage CS by CZE. Total 
alkali extracts were subject to chondroitinase ABC 
digestion. The resultant mixture of CS disaccharide 
isomers were quantified by capillary zone electrophor- 
esis. The ADi-4S ( I )  and ADi-6S ([]) isomer content of 
the mouse lateral (a) and medial (b) tibial articular 
cartilage is expressed as mg per mg wet cartilage. Each 
point is the mean _+ S.E.M. from 2-3 animals. Asterisks 
denote statistically significant differences between CBA 
(C) and STR/Ort (S) mice: *P<0.1; **P<0.05; 
***P <0.02; ****P < 0.002 (P ~< 0.001 for the overall 
mean difference between the two mouse strains for both 
the lateral and medial cartilage). 
lower (P < 0.001 for  the overal l  mean difference for 
both medial and lateral  plateaux). 
To examine whether  the elevated CS content  in 
STR/Ort  cart i lage is due only to a dif ference in 
gender or strain we compared 18-week-old STR/Ort  
mice of both sexes with male and female CBA and 
Balb C mice of s imilar age. Measurements  were 
made with both analyt ica l  methods. The results 
(Fig. 4) demonstrate  that  the high CS content  is a 
character ist ic  of only male STR/Ort  mice. 18-week 
female STR/Ort  mice as well as male and female 
CBA and Balb C mice all had a much lower t ibial 
art icu lar  cart i lage CS. 
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EXTRACTABILITY OF PROTEOGLYCAN FROM MOUSE 
ARTICULAR CARTILAGE 
Table I shows the proportion of the total proteo- 
glycan solubilized in the first GuHC1 extract (El) 
for both medial and lateral tibial cartilage in 
STR/Ort and CBA mice at 8, 24 and 48 weeks of age. 
Comparing CBA and STR/Ort mice at each age 
there were no P-values smaller than 0.23. Thus 
there are no obvious differences in extractabil ity 
between the two strains. Nor do proteoglycans of
the STR/Ort medial plateau, where lesions develop, 
appear to be more readily extracted than those of 
the lateral plateau. 
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FIG. 3. Chondroitin 4:6 sulfate isomer ratios in the 
cartilage of CBA and STR/Ort mice. The CS disaccharide 
isomers were quantified by CZE as described in Fig. 2. 
The results, presented as the mean_ S.~..M. show the 
ratio of ADi-4S:ADi-6S isomers in the lateral (m) and 
medial ([]) tibial articular cartilage for both CBA (a) 
and STR/Ort mice (b). Asterisks denote statistically 
significant differences between the lateral and medial 
tibial articular cartridge: *P < 0.1; **P < 0.05; 
***P <0.02 and ****P <0.01. For the overall mean 
difference between lateral and medial cartilage 
P < 0.0001 and P = 0.003 for CBA and STR/Ort mice 
respectively. 
IDENTIFICATION OF MURINE ARTICULAR CARTILAGE 
PROTEOGLYCANS 
The extracted proteoglycans were analysed by 
large pore gel electrophoresis and Western blot- 
ting. After transferring the proteoglycans to a 
nylon membrane and digesting with chondroit in 
lyase ABC they were probed with mabs 2B6 and 
3B3. These detect he 4- and 6-sulfated unsaturated 
disaccharides left on the nonreducing end of the 
linkage region of the CS chains removed by the 
lyase. Neither antibody revealed any notable 
differences in the proteoglycan species present in 
CBA and STR/Ort articular cartilage at 8, 24 or 48 
weeks of age (Fig. 5). Three proteoglycan bands of 
differing mobility were substituted with ADi-4S 
and presumably carried chains of the same compo- 
sition. The two slower mobility bands also 
contained ADi-6S and similarly are presumed to 
carry C6S chains. 
The mab 1C6, which detects epitopes in the core 
protein of aggrecan, was used to re-probe the 
membranes: Only the two bands of slower mobility 
were detected in both species at each age exam- 
ined. (Representative photographs obtained for 48 
week male STR/Ort mice are shown in Fig. 6.) Thus 
these two out of the three proteoglycan species are 
identified as aggrecan. The third C4S-rich proteo- 
glycan is as yet unidentified. 
Discuss ion  
Osteoarthritic lesions appear in the medial tibial 
cartilage of STR/Ort mice in the Charing Cross 
colony from about 20 weeks of age and by 48 weeks 
histopathological changes are found in 85~/o f the 
male animals. Initially, roughening of the cartilage 
surface occurs, followed by the development of 
erosions, fibrillations, and in some animals loss of 
cartilage fragments down to the level of the  
tidemark [19]. In contrast, the incidence of OA in 
CBA mice is extremely low. We have not detected 
histological evidence of the disease in serial sec- 
tions of knee joints from over one hundred CBA 
mice (Chambers and Mason, unpublished results). 
Thus CBA male mice were used as controls in the 
present experiments. 
We have shown that from an early age, and prior 
to the development of histological OA lesions, the 
CS content in the tibial articular cartilage of 
STR/Ort mice is elevated compared to that of CBA 
controls. Both C4S and C6S are increased. Proteo- 
glycan biosynthesis involves the co-ordination 
of protein synthesis and post-translational 
glycosyl transferase activity to form the 
glycosaminoglycan chains [20]. Thus increased 
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FIG. 4. Measurement ofglycosaminoglycans in 18 week mice of different strain and sex. Glycosaminoglycans were alkali 
extracted from the medial (a, c) and lateral (b, d) tibial articular cartilage of 18 week male (M) and female (F) STR/Ort 
(ST), CBA (CB) and Balb C (BC) mice. The extracts were quantified by l°3ruthenium red blot assay (a, b). In addition, 
each extract was digested with chondroitinase ABC and the resultant ADi-4S ( i )  and ADi-6S ([]) isomers quantified 
by CZE analysis (c, d). Data is expressed as mean ± S.E.M. with 2-4 mice per group. A statistical comparison was made 
between the male STR/Ort mice and all other categories: *P<0.1; **P<0.02; ***P <0.01; ****P < 0.005; 
*****P < 0.001. (For the overall mean difference between male STR/Ort mice vs the rest P < 0.0001 for Fig. 4a and 4b, 
P < 0.003 for Fig. 4c and P < 0.013 for Fig, 4d). 
amounts of CS could represent an increase in 
normal ly g lycoslyated proteoglycans,  or be due to 
subst i tut ion of the core protein with either 
addit ional or longer CS chains. Alternatively,  
addit ional proteoglycans of a different species may 
be synthesized. The results of the Western analyses 
rule out the latter. Two of the three proteoglycans 
in STR/Orr cart i lage were identified as aggrecan 
by their react iv i ty with the mab 1C6. This ant ibody 
does not have any cross react iv i ty  with large 
Table I 
Extractability of proteoglycans from STR /Ort and CBA mouse cartilage. 
Tibial articular cartilages from CBA and STR/Ort mice aged 8, 24 and 
48 weeks were dissected and extracted sequentially with 4 M GuHC1 (El), 
ultrapure collagenase, 4 M GuHCl (E2) and 0.5 M NaOH (E3). The amount 
of proteoglycan present in the El, E2 and E3 extracts was quantified by 
l°3ruthenium red dot blot analysis. The data, expressed as the 
mean +_ S.E.M. from two mice of each strain and age, shows the proportion 
of proteoglycan extracted by the first GuHCl extract (El) expressed as a 
percentage of the total (El + E2 + .E3) 
CBA STR/Ort 
Age in weeks Lateral Medial Lateral Medial 
8 36.5 ± 9.8 15.0 ± 4.7 34.9 ± 5.6 21.4 _+ 6.2 
24 46.0 ± 14.4 55.1 ± 17.1 69.5 ± 10.5 37.4 _+ 3.7 
48 22.1 ± 10.0 44.7 ± 13.6 40.7 ± 11.7 43.8 _+ 8.1 
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Fro. 5. Western blot analysis of mouse cartilage proteoglycans. Proteoglycans were extracted with 4 M GuHC1 (El) from 
the lateral (L) and medial (M) tibial articular cartilage of 24 week STR/Ort (S) and CBA (C) mice. After quantification 
by ~°~ruthenium reddot blot analysis, extracted proteoglycans wereseparated by dissociative large pore agarose-acryl- 
amide gel electrophoresis. Separated proteoglycans were blotted onto nylon membranes and probed with mabs 2B6 
(C4S) and 3B3 (C6S). Epitopes were visualized using an HRP-conjugated secondary antibody coupled with ECL 
detection. 
aggregating CS proteoglycans of the versican 
family [21]. Both STR/Ort aggrecan bands have the 
same mobility as those present i  CBA cartilage, as 
does the third band, a fast migrating C4S proteo- 
glycan. No additional proteoglycan species were 
detected in the STR/Ort extracts. Moreover, 
Rostand et al. [7] showed no qualitative differences 
in the size of proteoglycan monomer or gly- 
cosaminoglycan chains between the STR/1N 
mouse and controls. This suggests that the high 
level of glycosaminoglycan in STR/Ort tibial carti- 
lage is due to increased eposition in the tissue of 
proteoglycans of normal structure. Increased 
deposition could occur due to increased synthetic 
activity or because of reduced catabolism in the 
tissue. Preliminary experiments indicated that 
cartilage from 12-week male STR/Ort mice which 
had been pulse labelled in vivo with 35S-sulfate 
incorporated more isotope into their GAG chains 
than age-matched controls. Many investigators 
have reported that OA cartilage is metabolically 
more active than normal cartilage, as measured by 
the incorporation of ~SS-sulfate [22-27]. However, 
1C6 2B6 
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FIG. 6. Identification of aggrecan core protein by West- 
ern blot analysis. Western blot analysis was performed 
as described in Fig. 5. In agreement with the 24 week 
data, the lateral (L) and medial (M) tibial articular 
cartilage from 48 week STR/Ort (S) mice probed with 
mab 2B6 showed three C4S-rich proteoglycan species. 
When the same blot was re-probed with mab 1C6 only 
the two bands of slower mobility contained epitopes 
consistent with the aggrecan core protein. 
other groups have not found this and suggest hat 
there is either no difference or even a slight 
decrease in activity in OA cartilage [28-31]. One 
factor affecting the results of such investigations 
may be the age of the animal and the stage of the 
OA. 
The high level of cartilage CS found in young 
STR/Ort mouse cartilage undergoes a marked 
reduction in the period between 19 and 25 weeks. 
This coincides with the time when histological 
lesions of OA first appear in the medial tibial 
plateau in some mice. Following this there is an 
increase in the amount of proteoglycan i mice of 
31 weeks or older. One speculation is that a general 
increase in proteoglycan synthesis leads to in- 
creased eposition of the macromolecules in young 
cartilage. A relatively sudden decrease in proteo- 
glycan and the appearance of OA lesions may 
correspond to a period of enhanced catabolism, a 
response by the tissue perhaps to earlier excessive 
deposition. Finally, following this, the late phase 
increase in proteoglycan content of the tissue may 
be the result of those chondrocytes in undamaged 
parts of the cartilage increasing synthesis over 
catabolism as they respond to signals initiated by 
local matrix depletion or damage. 
The major proteoglycan present in both mouse 
strains is aggrecan. Despite the marked reduction 
in proteoglycan content in STR/Ort carti lage 
between 19-24 weeks we found no evidence in 
tissue extracts of bands representing proteoglycan 
degradation products (Figs 5 & 6). This is not 
surprising since large aggrecan products arising 
from proteolytic cleavage of the hyaluronan 
binding region (G1 domain) would not necessarily 
separate from the normal population of intact 
molecules on agarose-acrylamide gels, whilst small 
fragments may be rapidly lost by either diffusion to 
the synovial fluid or by catabolism by chondro- 
cytes. Moreover, other studies have shown that the 
majority of aggrecan monomers in OA cartilage 
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are fully functional with respect to binding 
hyaluronan [7, 32]. 
In agreement with Rostand et al. [7], our data 
show that C4S is the predominant isomer at all 
ages. Measurement of the 4:6 CS ratio on both 
sides of the joint in the CBA mice showed that it 
was greater in the lateral than the medial tibial 
cartilage, especially in younger animals. This 
could reflect a difference in the distribution or 
activity of sulfotransferase enzymes in the tissue, 
but the functional significance of the isomer atio, 
if any, is not currently understood. However, no 
such age-related differences in the ratio occurred 
between the lateral and the medial sides in the 
STR/Ort mice. They all had a higher proportion of 
C6S in their cartilage on both sides of the joint. 
This clear difference between the isomer ratio in 
the normal CBA mouse and the STR/Ort mouse at 
an early age and before OA lesions appear in the 
latter raises the question as to whether it relates 
in any way to the development of the disease. 
The relevance of these observations to human 
disease is not known, particularly since the pre- 
dominant isomer in normal human adult articular 
cartilage is C6S [33]. It has been reported that in 
human OA cartilage there is a concomitant de- 
crease in this isomer relative to C4S [34], and 
Shinmei et al. [35] found a relative increase in the 
C4S content of synovial fluids from the knee joints 
of patients with OA. Such changes may be due to 
the OA chondrocytes synthesizing a more 
immature, C4S-rich form of aggrecan, such as is 
found in fetal cartilage, and possibly to enhanced 
catabolism of decorin, which carries 4-sulfated 
chains [36, 37]. Similar changes hould not necess- 
arily be  expected in murine OA cartilage. The 
murine aggrecan core protein sequence differs 
from the human sequence [38]. C4S is the predom- 
inant isomer at all ages and, unlike the human 
proteoglycan, it carries no keratan sulfate chains 
[39]. Thus, direct comparisons between the two 
species are unlikely to be useful in understanding 
the significance of the different CS isomer atios in 
CBA and STR/Ort cartilage, which remains 
elusive. 
Due to the very small size of the mouse joints, it 
was not possible to carry out histological and 
biochemical investigations on the same joint. How- 
ever, a separate histological study revealed that 
overt changes were seen in the STR/Ort mice from 
about 20 weeks onwards [19]. No comparable OA 
changes were seen in CBA mice [10]. McDevitt and 
Muir [3] suggested that the 'metabolism of articu- 
lar cartilage as a whole appears to be affected in 
OA--not merely focal areas where the cartilage 
surface is damaged and lesions develop'. Our 
results may support this view since we found 
biochemical differences between CBA and STR/Ort 
cartilage at an age prior to the appearance of OA 
lesions in the latter. Moreover, in contrast o the 
biochemical differences which occurre~d in both 
sides of the joint, the histological OA changes were 
confined almost exclusively to the medial tibial 
cartilage. It is not known whether the biochemical 
changes are primary or secondary to the disease 
process, but ~ restriction of the histological lesion to 
the medial side suggests that a specific factor(s) 
acts on that cartilage to induce lesions. One 
possibility is that the mechanical forces to which 
the medial and lateral cartilages" are exposed may 
differ. 
In humans, OA is more prevalent in females. In 
contrast, in many mouse strains, including 
STR/Ort mice, spontaneous disease is more com- 
mon in males [40]. However, in the closely related 
STR/1N mouse, OA does not depend on male sex 
hormones, and castration has little or no effect on 
the incidence of the disease [41]. STR/1N and 
STR/Ort mice have several abnormalities in 
addition to OA. Both have an increased incidence 
of obstructive genitourinary disease [41-43] and in 
the STR/1N strain this was prevented by castration 
[42]. Growth plate abnormalities were reported in 
STR/1N, including irregularity of the chondrocyte 
columns, abnormal vascularization and focal 
necrosis [44, 45]. These changes were not seen in 
STR/Ort mice [5]. A high incidence of spontaneous 
hepatomas has also been reported in the STR/1N 
strain [46]. STR/Ort mice have a high incidence of 
patellar displacement and, in some colonies, 
calcification of ligaments occurs [5, 43 47]. How 
these various abnormalities relate to OA is not 
known. They may be unrelated to one another or, 
alternatively some, or all, may be secondary mani- 
festations of an underlying metabolic defect. Nev- 
ertheless, animal models may hold the key to our 
eventual understanding of the processes that lead 
to cartilage degeneration. Further studies are 
required before the value of the STR/Ort model can 
be assessed. 
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